Diego de Miguel‐Pérez

Author

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research ORCID

Also Known As

A. Leyva, D Perez, D Pérez, D. De Miguel Perez, D. De Miguel-Perez, D. De Miguel-Pérez, D. Miguel-Pérez, D. Perez, D. Pérez, D. de Miguel Perez

135

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research Universidad de Granada University of Maryland, Baltimore University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Foundation for Clinical and Applied Cancer Research

About

Diego de Miguel‐Pérez is an author at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	177
2	Cell Biology	3	3	129
3	Health Sciences	1	1	11
4	Natural Sciences	1	1	77
5	Biomedical Engineering	1	1	77

Diego de Miguel‐Pérez

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy Alba Rodríguez‐Martínez, Diego de Miguel‐Pérez, Francisco G. Ortega, Breast Cancer Research	2019	179
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients Diego de Miguel‐Pérez, Alba Rodríguez‐Martínez, Alba Ortigosa‐Palomo, Scientific Reports	2020	116
Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection Clara Bayarri-Lara, Francisco G. Ortega, Antonio Cueto Ladrón de Guevara, PLoS ONE	2016	114
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer Diego de Miguel‐Pérez, Alessandro Russo, Óscar Arrieta, Journal of Experimental & Clinical Cancer Research	2022	97
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) Mohamed A. Gouda, Filip Jankú, Adam Wahida, Annals of Oncology	2023	87
Interfering with endolysosomal trafficking enhances release of bioactive exosomes Francisco G. Ortega, Marieke T. Roefs, Diego de Miguel‐Pérez, Nanomedicine Nanotechnology Biology and Medicine Cell-derived Extracellular VesiclesExtracellular MicrovesiclesBiomedical EngineeringTherapeuticsRegenerative Medicine	2019	77
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior Alba Rodríguez‐Martínez, Iris Simón, Sonia Perales, Theranostics	2022	61
Improving extracellular vesicles visualization: From static to motion Pablo Reclusa, Peter Verstraelen, Simona Taverna, Scientific Reports	2020	51
Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma Diego de Miguel‐Pérez, Clara Bayarri-Lara, Francisco G. Ortega, Cancers	2019	48
Sandwich-Type Electrochemical Paper-Based Immunosensor for Claudin 7 and CD81 Dual Determination on Extracellular Vesicles from Breast Cancer Patients Francisco G. Ortega, Matías Regiart, Alba Rodríguez‐Martínez, Analytical Chemistry	2020	46

Page 1